Twelfth Magpie Premium
  1. Stocks
    2. /
  2. Editas Medicine (NASDAQ: EDIT)
    3. /

NASDAQ:EDIT (Editas Medicine)

Market Data powered by QuoteMedia. Copyright © 2026. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

Editas Medicine (NASDAQ: EDIT)
Latest News

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing Articles

Could buying this gene-editing penny stock at $1 make me rich?

| Ben McPoland

This writer digs into the CRISPR gene-editing space, asking whether one particular penny stock is worth taking a punt on…

Read more »

Genetic Techs with the text “Investing in Genetics Top UK Genetics Stocks in 2022” and The Motley Fool jester cap logo

Investing in Genetics: Top UK Genetics Stocks of 2026

| Zaven Boyrazian, CFA

Explore the world of UK genetics stocks and discover the leading businesses offering explosive growth potential in 2026. Here’s what…

Read more »